Hyperinsulinemic Hypoglycemia in Infancy: Current Concepts in Diagnosis and Management (Q26771689)

https://api.crossref.org/works/10.1007%2FS13312-015-0772-1

Triggering and amplifying pathways of regulation of insulin secretion by glucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13312-015-0772-1

Congenital hyperinsulinism: current status and future perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13312-015-0772-1

Reconstitution of IKATP: an inward rectifier subunit plus the sulfonylurea receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13312-015-0772-1

Mechanisms of amino acid-stimulated insulin secretion in congenital hyperinsulinism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13312-015-0772-1

Defining neonatal hypoglycaemia: a continuing debate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13312-015-0772-1

Postnatal glucose homeostasis in late-preterm and term infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13312-015-0772-1

Hyperinsulinaemic hypoglycaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13312-015-0772-1

Characteristics of infants at risk of hypoglycaemia secondary to being 'infant of a diabetic mother'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13312-015-0772-1

ABCC8 and KCNJ11 molecular spectrum of 109 patients with diazoxide-unresponsive congenital hyperinsulinism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13312-015-0772-1

The genetic basis of congenital hyperinsulinism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13312-015-0772-1

Paternal mutation of the sulfonylurea receptor (SUR1) gene and maternal loss of 11p15 imprinted genes lead to persistent hyperinsulinism in focal adenomatous hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13312-015-0772-1

Update of mutations in the genes encoding the pancreatic beta-cell K(ATP) channel subunits Kir6.2 (KCNJ11) and sulfonylurea receptor 1 (ABCC8) in diabetes mellitus and hyperinsulinism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13312-015-0772-1

Hyperinsulinism and hyperammonemia in infants with regulatory mutations of the glutamate dehydrogenase gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13312-015-0772-1

Hyperinsulinism of infancy associated with a novel splice site mutation in the SCHAD gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13312-015-0772-1

Molecular mechanisms of protein induced hyperinsulinaemic hypoglycaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13312-015-0772-1

Severe persistent hyperinsulinemic hypoglycemia due to a de novo glucokinase mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13312-015-0772-1

Mutations in UCP2 in congenital hyperinsulinism reveal a role for regulation of insulin secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13312-015-0772-1

Macrosomia and hyperinsulinaemic hypoglycaemia in patients with heterozygous mutations in the HNF4A gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13312-015-0772-1

Physical exercise-induced hyperinsulinemic hypoglycemia is an autosomal-dominant trait characterized by abnormal pyruvate-induced insulin release

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13312-015-0772-1

Hyperinsulinism and Beckwith-Wiedemann syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13312-015-0772-1

Congenital disorder of glycosylation id presenting with hyperinsulinemic hypoglycemia and islet cell hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13312-015-0772-1

Hyperinsulinism in tyrosinaemia type I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13312-015-0772-1

Clinical and molecular characterisation of 300 patients with congenital hyperinsulinism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13312-015-0772-1

Hypoglycemic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13312-015-0772-1

Long-term neurodevelopmental outcome in conservatively treated congenital hyperinsulinism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13312-015-0772-1

The investigation and management of neonatal hypoglycaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13312-015-0772-1

The molecular mechanisms, diagnosis and management of congenital hyperinsulinism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13312-015-0772-1

Continuous glucose monitoring in newborn babies at risk of hypoglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13312-015-0772-1

Investigations for neonatal hypoglycaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13312-015-0772-1

Hyperinsulinaemic hypoglycaemia: biochemical basis and the importance of maintaining normoglycaemia during management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13312-015-0772-1

Practical management of hyperinsulinism in infancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13312-015-0772-1

Liver injury may increase the risk of diazoxide toxicity: a case report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13312-015-0772-1

Diagnosis and management of hyperinsulinaemic hypoglycaemia of infancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13312-015-0772-1

Assessment of the role of interstitial glucagon in the acute glucose secretory responsiveness of in situ pancreatic beta-cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13312-015-0772-1

Sirolimus therapy in infants with severe hyperinsulinemic hypoglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13312-015-0772-1

Hyperinsulinaemic hypoglycaemia in preterm neonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13312-015-0772-1

Proposal for a standardized protocol for 18F-DOPA-PET (PET/CT) in congenital hyperinsulinism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13312-015-0772-1

The laparoscopic approach toward hyperinsulinism in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13312-015-0772-1

21 January 2018

Neonatal hypoglycemia

1 reference

https://api.crossref.org/works/10.1007%2FS13312-015-0772-1

7 January 2021

Continuous glucose monitoring system for congenital hyperinsulinemia

1 reference

https://api.crossref.org/works/10.1007%2FS13312-015-0772-1

7 January 2021

Recommendations from the Pediatric Endocrine Society for Evaluation and Management of Persistent Hypoglycemia in Neonates, Infants, and Children

1 reference

https://api.crossref.org/works/10.1007%2FS13312-015-0772-1

7 January 2021

Neonatal hypoglycemia

1 reference

https://api.crossref.org/works/10.1007%2FS13312-015-0772-1

7 January 2021

Treatment of congenital hyperinsulinism with lanreotide acetate (Somatuline Autogel)

1 reference

https://api.crossref.org/works/10.1007%2FS13312-015-0772-1

7 January 2021

Successful treatment of congenital hyperinsulinism with long-acting release octreotide

1 reference

https://api.crossref.org/works/10.1007%2FS13312-015-0772-1

7 January 2021